|
US2008045559A1
|
|
Tocopherol-modified therapeutic drug compounds
|
|
TW200731991A
|
|
Lipophilic di(anticancer drug) compounds, compositions and related methods
|
|
TW200731990A
|
|
Lipophilic anticancer drug compounds, compositions, and related methods
|
|
US2007129431A1
|
|
Multinuclear platinum compounds
|
|
WO2005118612A1
|
|
Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs
|
|
TW200534845A
|
|
Platinum carboxylate anticancer compounds
|
|
US2005209321A1
|
|
Platinum carboxylate anticancer compounds
|
|
CN1875022A
|
|
Tocopherol-modified therapeutic drug compounds
|
|
KR20060110872A
|
|
Tocopherol-modified therapeutic drug compounds
|
|
US2004092585A1
|
|
Platinum compounds
|
|
AU2003211131A1
|
|
Metformin salts of lipophilic acids
|
|
US6864386B1
|
|
Fluorinated compounds
|
|
US6858227B1
|
|
Vitamin E conjugates
|
|
US2003087954A1
|
|
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
|
US6727280B2
|
|
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
|
US2003065024A1
|
|
Emulsion vehicle for poorly soluble drugs
|
|
AU2002307237A1
|
|
Carboxybenzopyran derivatives and compositions
|
|
AU2002256154A1
|
|
Aminobenzopyran derivatives and compositions
|
|
US2003149099A1
|
|
Tocopherol derivatives
|
|
AU9482601A
|
|
Tocol-based compositions containing amiodarone
|
